AAP guidelines favor injectable influenza vaccine for kids

  • AAP Committee on Infectious Diseases
  • Pediatrics
  • 4 Sep 2018

  • curated by Liz Scherer
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • American Academy of Pediatrics (AAP) has released its 2018-2019 influenza season vaccination recommendations, reinforcing prevention for all children aged >6 months.

Why this matters

  • Clinicians should discuss recommendation with parents/caregivers, reinforcing severity of 2017-2018 season.
  • Children aged >6 months, especially those at high risk for complications, should be vaccinated as soon as vaccine is available (preferably by end of October).

Key points

  • Either trivalent or quadrivalent inactivated influenza vaccine (IIV3, IIV4, respectively) is the first-line option for influenza vaccination in children; selection is based on whatever is available locally.
    • IIV3 contains influenza A(Michigan/45/2015[H1N1]) pdm09-like virus, influenza A(Singapore/INFIMH-16-0019/2016[H3N2])-like virus (updated), and influenza B (Colorado/60/2017)-like virus (B/Victoria lineage; updated), and updated influenza A(H3N2, Singapore lineage) and influenza B (Victoria lineage) strains.
    • IIV4 contains an additional B virus (Phuket/3073/2013-like virus; B/Yamagata lineage).
  • Live attenuated influenza vaccine (LAIV) is an option for healthy children, >2 years, not otherwise receiving a vaccine (CDC recommends LAIV for all children). 
  • Number of doses to be delivered depends on age at the time of first administered dose, vaccine history.
  • Egg allergy is not a contraindication for influenza vaccination.
  • Any IIV3 or IIV4 vaccine may be used in pregnant women at any time during pregnancy.
  • Antivirals are not a substitute for vaccination.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit